<DOC>
	<DOCNO>NCT01264237</DOCNO>
	<brief_summary>The present study aim determine safety , efficacy , tolerability etoricoxib , NSAID pain reliever , patient Neuropathic pain . Neuropathic pain , pain cause abnormal activity sensory neuron , remain undertreated . Post herpetic neuralgia ( PHN ) , commonly refer post-shingles pain , useful disease study investigate efficacy pain reliever Neuropathic pain . Therefore , study primarily involve patient PHN . The hypothesis study etoricoxib efficacy superior placebo .</brief_summary>
	<brief_title>Evaluation Efficacy , Tolerability Safety Etoricoxib ( Arcoxia ) Patients With Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<criteria>Be man nonpregnant , nonlactating woman 18 year old . Women childbearing potential willing use acceptable birth control method ( investigator 's discretion ) study avoid pregnancy . Have voluntarily provide write informed consent . Be able speak , read , write , understand English , understand consent form , complete study related procedure , communicate study staff . Have clinical diagnosis PHN history objective finding opinion Investigator minimum 6 month . If patient pool need expand neuropathic condition , patient must meet criteria patient PHN addition must clinical diagnosis peripheral diabetic neuropathy ( PDN ) , idiopathic sensory neuropathy ( ISN ) small fiber predominant neuropathy ( SFN ) history clinical finding opinion investigator minimum 6 month . Have pain intensity score average â‰¥3 010 NRS average daily recall past 24 hour ( Visit 1 ) Be , opinion investigator , generally good health ( PHN ) screening , base upon result medical history , physical examination laboratory analysis Are pregnant and/or lactate Have diagnose inflammatory arthritis , gout , pseudogout , Paget 's disease , fibromyalgia chronic pain syndrome Investigator 's opinion would interfere assessment pain symptom PHN Have evidence multiple cause pain neuropathic pain area , lumbar radiculopathy area lumbosacral PHN Have bodily moderate severe pain ( e.g. , osteoarthritis ) could confound assessment selfevaluation pain due PHN Use NSAID compound ( oral topical ) within 1 week study duration study Use opioids include tramadol within 1 week study duration study . ( Other NP medication allow , provide dos stable least one month prior Visit 1 ) Have neuroablation neurosurgical intervention PHN Have receive nerve block intrathecal analgesia within 6 week study Have history congestive heart failure , unstable coronary artery disease , stroke , uncontrolled hypertension Have history significant gastrointestinal disease , include active gastroduodenal ulceration , perforation , bleeds Have abnormal clinical laboratory test result vital sign unless deem clinically significant investigator Have skin lesion damage area BSTK measurement conduct ( applicable PHN patient ) Are undergo active treatment cancer , know infected HIV , acutely intensively immunosuppressed follow transplantation Have history alcohol substance abuse ( include nicotine tobacco ) within five year Known condition investigator 's judgment preclude participation study Have significant psychiatric disorder opinion Investigator . Have receive investigational drug use investigational device 30 day prior study entry Have previously admit study Are allergic Arcoxia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Postherpetic neuralgia</keyword>
	<keyword>Neuropathic pain</keyword>
	<keyword>Etoricoxib</keyword>
</DOC>